A detailed history of Opus Capital Group, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Opus Capital Group, LLC holds 226,100 shares of SLS stock, worth $264,537. This represents 0.04% of its overall portfolio holdings.

Number of Shares
226,100
Previous 221,000 2.31%
Holding current value
$264,537
Previous $263,000 7.6%
% of portfolio
0.04%
Previous 0.04%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$1.08 - $1.39 $5,508 - $7,088
5,100 Added 2.31%
226,100 $283,000
Q2 2024

Jul 31, 2024

BUY
$1.06 - $1.63 $21,624 - $33,252
20,400 Added 10.17%
221,000 $263,000
Q1 2024

Apr 26, 2024

BUY
$0.51 - $1.55 $33,456 - $101,680
65,600 Added 48.59%
200,600 $203,000
Q4 2023

Jan 31, 2024

BUY
$0.88 - $1.57 $88,440 - $157,785
100,500 Added 291.3%
135,000 $143,000
Q3 2023

Oct 31, 2023

BUY
$1.42 - $1.83 $4,970 - $6,405
3,500 Added 11.29%
34,500 $56,000
Q2 2023

Jul 31, 2023

BUY
$1.35 - $1.8 $8,100 - $10,800
6,000 Added 24.0%
31,000 $49,000
Q1 2023

Apr 24, 2023

BUY
$1.18 - $3.86 $6,287 - $20,566
5,328 Added 27.08%
25,000 $36,000
Q4 2022

Jan 18, 2023

BUY
$1.8 - $5.41 $35,409 - $106,425
19,672 New
19,672 $46,000

Others Institutions Holding SLS

About SELLAS Life Sciences Group, Inc.


  • Ticker SLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,551,900
  • Market Cap $24M
  • Description
  • SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...
More about SLS
Track This Portfolio

Track Opus Capital Group, LLC Portfolio

Follow Opus Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opus Capital Group, LLC with notifications on news.